• Login
  • For Providers
  • For Biosciences
  • News
  • Who We Are
  • Contact
EMOL Health
  • Contact
  • Login
  • For Providers
  • For Biosciences
  • Who We Are
  • News
Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks

by EMOL Admin | Jun 12, 2023 | Technology

Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer that affects younger individuals and African Americans disproportionately. EMOL Health took part with researchers studying TNBC’s pathways and found that targeting certain genes (STAT3, GLI, and...

Recent Posts

  • EMOL Health Poster Presentation at NCCN
  • NCCN 2025
  • EMOL Health Participates in AVBCC  
  • EMOL Health Poster Presentation at WCLC  
  • IASLC World Conference on Lung Cancer

5158 Elmhurst Ave
Royal Oak MI 48073

Office: 248.434.1670

Fax: 248.928.7036

Privacy Policy

Copyright ©2024-2025 EMOL Health